Canadian scientists develop blood test to quickly predict risk of sepsis

A team of scientists from across Canada has developed an innovative molecular-based blood test and portable device to quickly predict the risk of sepsis over the first 24 hours of clinical presentation. READ MORE

A research paper describing the test and its development was published in Nature Communications. It represents a major milestone in the way doctors will evaluate and treat sepsis. The study was the result of a collaboration between three multi-disciplinary teams. Dr. Pamela Plant and Dr. Claudia dos Santos at St. Michael’s Hospital/Unity Health Toronto, Dr. Robert Hancock at the University of British Columbia and Dr. Peter Zhang at Sepset Inc., and Dr. Lidija Malic and Dr. Teodor Veres at the National Research Council of Canada’s (NRC) Medical Devices Research Centre.

Dr. dos Santos had been a McLaughlin Centre Accelerator Grantee in 2015 and 2021.